References
- Pavlou E, Phylactides M, Kyrri A, et al. δ-Thalassemia in Cyprus. Hemoglobin. 2006;30(4):455–462.
- Bouva MJ, Harteveld CL, van Delft P, Giordano PC. Known and new δ globin gene mutations and their diagnostic significance. Haematologica. 2006;91(1):129–132.
- Thompson RB, Odom J, Warrington R, Bell WN. Thalassemia with complete absence of Hemoglobin A2 in an adult. Acta Haematol. 1965;33(3):186–190.
- Yasukawa M, Saito S, Fujita S, et al. Five families with homozygous δ-thalassaemia in Japan. Br J Haematol. 1980;46(2):199–206.
- Yan JM, Wu MY, Xie XM, Li DZ. Heterozygous β-thalassemia with complete absence of Hemoglobin A2 in a Chinese adult. Int J Lab Hematol. 2015;37(6):e147–e149.
- Liu N, Xie XM, Zhou JY, et al. Analysis of δ-globin gene mutations in the Chinese population. Hemoglobin. 2013;37(1):85–93.
- Matsuda M, Sakamoto N, Fukumaki Y. δ-Thalassemia caused by disruption of the site for the erythroid-specific transcription factor, GATA-1, in the δ-globin gene promoter. Blood. 1992;80(5):1347–1351.
- Giambona A, Passarello C, Renda D, Maggio A. The significance of the Hemoglobin A2 value in screening for hemoglobinopathies. Clin Biochem. 2009;42(18):1786–1796.
- Mosca A, Paleari R, Ivaldi G, et al. The role of Haemoglobin A2 testing in the diagnosis of thalassaemias and related haemoglobinopathies. J Clin Pathol. 2009;62(1):13–17.
- Jenkins MA, Hendy J, Smith IL. Evaluation of Hemoglobin A2 quantitation assay and hemoglobin variant screening by capillary electrophoresis. J Capillary Electrophor. 1997;4(3):137–143.
- Liu D, Zhang X, Yu L, et al. KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of β-thalassemia. Blood. 2014;124(5):803–811.
- Perkins A, Xu X, Higgs DR, et al. KLF1 Consensus Workgroup. Krüppeling erythropoiesis: an unexpected broad spectrum of human red blood cell disorders due to KLF1 variants. Blood. 2016;127(15):1856–1862.